Details of Drug

Details of Drug

 Drug General Information (ID: D1273)
  Drug Name
Phenylacetic acid
  Drug Type Small molecule
  Drug Synonymous
PHENYLACETIC ACID; 2-Phenylacetic acid; Benzeneacetic acid; 103-82-2; Phenylethanoic acid; alpha-Toluic acid; phenylacetate; Benzenacetic acid; Acetic acid, phenyl-; Benzylformic acid; Phenyllacetic acid; Benzylcarboxylic acid; PHENYL ACETIC ACID; Kyselina fenyloctova; Phenylacetic acid (natural); Kyselina fenyloctova [Czech]; omega-Phenylacetic acid; UNII-ER5I1W795A; NSC 125718; BRN 1099647; .alpha.-Toluic acid; CHEBI:30745; AI3-08920; PHENYL-ACETIC ACID; .omega.-Phenylacetic acid; CHEMBL1044; ER5I1W795A; Benzeneacetate; MFCD00004313; NSC125718; NCGC00159477-02; DSSTox_CID_1656; DSSTox_RID_76268; DSSTox_GSID_21656; 1173020-54-6; CAS-103-82-2; FEMA No. 2878; HSDB 5010; EINECS 203-148-6; Phenylacetic; Phenylethanoate; Phenylessigsaure; w-Phenylacetate; alpha-Toluate; phenylactic acid; a-Toluate; a-Toluic acid; Benzeneacetiic acid; omega-Phenylacetate; organic white solid; w-Phenylacetic acid; Phenylacetate, XIX; 2-phenyl-acetic acid; Phenylacetic acid, 99%; bmse000220; Epitope ID:116202; EC 203-148-6; SCHEMBL1459; 4-09-00-01614 (Beilstein Handbook Reference); Phenyl-[13C6]-acetic acid; DTXSID2021656; BDBM16419; ZINC388462; Phenylacetic acid_GurudeebanSatyavani; Tox21_113042; Tox21_200533; NSC139637; Phenylacetic acid, natural, >=99%; STK297835; Phenylacetic acid, analytical standard; AKOS000291351; Tox21_113042_1; DB09269; DL-0063; MCULE-6701370784; NSC-125718; NSC-139637; Phenylacetic acid, >=99%, FCC, FG; NCGC00159477-03; NCGC00159477-05; NCGC00258087-01; 51146-16-8; BP-11383; NCI60_000596; NCI60_002571; Phenylacetic acid, natural, >=99%, FG; DB-003759; DB-055176; FT-0641197; FT-0701063; Phenylacetic acid, plant cell culture tested; C07086; Q410842; 8727557E-AA75-49E9-8E5A-7A2412D71888; Tropicamide Related Compound D, United States Pharmacopeia (USP) Reference Standard; 17303-65-0; Tropicamide impurity D (Phenylacetic acid - Drug Precursor), European Pharmacopoeia (EP) Reference Standard
    Click to Show/Hide
  Therapeutic Class Antihyperammonia Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C8H8O2
  InChI InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)
  InChIKey WLJVXDMOQOGPHL-UHFFFAOYSA-N
  Canonical SMILES C1=CC=C(C=C1)CC(=O)O
  External Link
Pubchem ID 999
VARIDT ID DR00333

Drug-Drug Interaction Network
  Sunburst Graph
AM005  Affected excretion pathways
AM007  Pharmacodynamic antagonistic effects
BM028  Competitive inhibition of renal tubular secretion
BM088  Antagonize the effect of anti-hyperammonemia agents
  Relation Graph
 Full list of drugs interacting with Phenylacetic acid
      Affected excretion pathways
   Competitive inhibition of renal tubular secretion Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1341
 
Probenecid
 
C13H19NO4S
 
4911 
Moderate    Inter Info   
[1]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of anti-hyperammonemia agents Drug Num:  1
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D1677
 
Valproic acid
 
C8H16O2
 
3121 
Major    Inter Info   
[1], [2], [3]
References
1 Product Information. Ammonul (sodium benzoate-sodium phenylacetate). Ucyclyd Pharma, Scottsdale, AZ.
2 Product Information. Depakene (valproic acid). Abbott Pharmaceutical, Abbott Park, IL.
3 Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.